![Kay Kwok Ng](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kay Kwok Ng
Corporate Officer/Principal en CPA Australia Ltd. .
Cargos activos de Kay Kwok Ng
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CPA Australia Ltd.
![]() CPA Australia Ltd. Miscellaneous Commercial ServicesCommercial Services CPA Australia Ltd. is an Australian company that has been operating since 1954 and provides education, training, technical support, and advocacy services in the accounting profession. The private company is based in Southbank, Australia and has subsidiaries in Hong Kong. The company engages with governments, regulators, and industries to advocate for policies that stimulate sustainable economic growth. With over 166,000 members working in 100 countries and regions, CPA Australia is one of the world's largest accounting bodies. It was founded in 1886 by Andrew Lyell, Arthur Cleveland, Benjamin Doughty Smith, Thomas Brentnall, John McAlister Howden, Charles Morell Holmes, William Crellin, and Edward Langton. Andrew Paul Hunter has been the CEO of the company since 2018. | Corporate Officer/Principal | 29/03/2010 | - |
Historial de carrera de Kay Kwok Ng
Antiguos cargos conocidos de Kay Kwok Ng.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CCIAM FUTURE ENERGY LIMITED | Director/Miembro de la Junta | 15/08/2018 | 01/09/2020 |
Independent Dir/Board Member | 15/08/2018 | 01/09/2020 | |
GOFINTECH INNOVATION LIMITED | Director/Miembro de la Junta | 14/09/2007 | 13/12/2019 |
Independent Dir/Board Member | 14/09/2007 | 13/12/2019 | |
NOIZ GROUP LIMITED | Director/Miembro de la Junta | 26/07/2013 | 01/04/2019 |
Independent Dir/Board Member | 26/07/2013 | 01/04/2019 | |
GET HOLDINGS LIMITED | Director/Miembro de la Junta | 01/01/2007 | 24/05/2013 |
Director Ejecutivo | 01/01/2007 | 24/05/2013 | |
Secretario Corporativo | 01/01/2007 | 31/05/2011 | |
Everpride Biopharmaceutical Co. Ltd.
![]() Everpride Biopharmaceutical Co. Ltd. Pharmaceuticals: OtherHealth Technology Everpride Biopharmaceutical Co. Ltd. principal activities are manufacturing and selling of medicines known as 'Plasmin Capsule' and 'Puli Capsule'. Plasmin capsule has the principal effect of resolving blood clots and may be used for treatment of cardiovascular diseases. Puli capsule has the principal effect of treating osteoarthritis. Other activity includes investment holding. Operations are carried out in the People's Republic of China. Everpride Biopharmaceutical Co. Ltd. was incorporated in the Cayman Islands on 1 August 2000 | Director/Miembro de la Junta | 08/04/2010 | 22/04/2010 |
Formación de Kay Kwok Ng.
Australian National University | Undergraduate Degree |
Macquarie University | Undergraduate Degree |
Estadísticas
Internacional
Hong-Kong | 6 |
Australia | 4 |
Operativa
Director/Board Member | 5 |
Independent Dir/Board Member | 3 |
Undergraduate Degree | 2 |
Sectorial
Finance | 3 |
Commercial Services | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
GOFINTECH INNOVATION LIMITED | Finance |
GET HOLDINGS LIMITED | Technology Services |
NOIZ GROUP LIMITED | Finance |
CCIAM FUTURE ENERGY LIMITED | Commercial Services |
Empresas privadas | 2 |
---|---|
CPA Australia Ltd.
![]() CPA Australia Ltd. Miscellaneous Commercial ServicesCommercial Services CPA Australia Ltd. is an Australian company that has been operating since 1954 and provides education, training, technical support, and advocacy services in the accounting profession. The private company is based in Southbank, Australia and has subsidiaries in Hong Kong. The company engages with governments, regulators, and industries to advocate for policies that stimulate sustainable economic growth. With over 166,000 members working in 100 countries and regions, CPA Australia is one of the world's largest accounting bodies. It was founded in 1886 by Andrew Lyell, Arthur Cleveland, Benjamin Doughty Smith, Thomas Brentnall, John McAlister Howden, Charles Morell Holmes, William Crellin, and Edward Langton. Andrew Paul Hunter has been the CEO of the company since 2018. | Commercial Services |
Everpride Biopharmaceutical Co. Ltd.
![]() Everpride Biopharmaceutical Co. Ltd. Pharmaceuticals: OtherHealth Technology Everpride Biopharmaceutical Co. Ltd. principal activities are manufacturing and selling of medicines known as 'Plasmin Capsule' and 'Puli Capsule'. Plasmin capsule has the principal effect of resolving blood clots and may be used for treatment of cardiovascular diseases. Puli capsule has the principal effect of treating osteoarthritis. Other activity includes investment holding. Operations are carried out in the People's Republic of China. Everpride Biopharmaceutical Co. Ltd. was incorporated in the Cayman Islands on 1 August 2000 | Health Technology |
- Bolsa de valores
- Insiders
- Kay Kwok Ng
- Experiencia